The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases

Appreciation of the properties of arsenic trioxide (ATO) has redefined the treatment landscape for acute promyelocytic leukaemia (APL) and offers promise as a treatment for numerous other diseases. The benefits of ATO in patients with APL is related to its ability to counteract the effects of PML::R...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Lynn, Kumana, Cyrus R., Kwong, Yok-Lam, Gill, Harinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504237/
https://www.ncbi.nlm.nih.gov/pubmed/36145693
http://dx.doi.org/10.3390/pharmaceutics14091945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504237/
https://www.ncbi.nlm.nih.gov/pubmed/36145693
http://dx.doi.org/10.3390/pharmaceutics14091945

Ejemplares similares